A recent investigation unveiled a non-transcriptional regulation of YAP/TAZ signaling in glioblastoma multiforme (GBM), pinpointing IMP1 as one of the highly expressed RNA binding proteins (RBPs) in mesenchymal GBM and glioma stem‐like cells (GSCs). Here, YAP1 is linked to central nervous system cancer.